TrialsgrambetaRCTs are beautiful

ANDROMEDA-SHOCK 2 Trial

Trials extracted from the podcast by Rob Mac Sweeney

Aired
24 Sept 2026

Studies discussed6

  • 2025
    ANDROMEDA-SHOCK-2ICU & Critical Care
    In 1,501 patients with early septic shock, capillary refill time-targeted personalised resuscitation improved a hierarchical outcome of death, vital support and hospital stay compared with usual care.
    Read →
  • 2019
    ANDROMEDA-SHOCKICU & Critical Care
    In 424 adults with early septic shock, capillary refill time-targeted resuscitation did not significantly reduce 28-day mortality compared with lactate-targeted resuscitation.
    Read →
  • 2010
    LACTATEICU & Critical Care
    In ICU patients with lactate ≥3 mEq/L, lactate-guided resuscitation did not significantly reduce hospital mortality compared with standard care blinded to lactate.
    Read →
  • 2015
    PPTFMICU & Critical Care
    In 30 ICU patients with septic shock, fluids guided by peripheral perfusion gave non-significantly less fluid and lower early SOFA scores than standard systemic haemodynamic targets.
    Read →
  • 2017
    In 95 ED patients with sepsis and hyperlactatemia, abnormal capillary refill after initial fluids predicted higher hospital mortality than normal capillary refill.
    Read →
  • 2020
    In 186 matched patients with septic shock, very early norepinephrine was associated with lower 28-day mortality and less fluid compared with starting it after initial fluid loading.
    Read →